MESA LABORATORIES INC CO
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
MLAB$136.91+7.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
(dollars in thousands, except per share data)
| Common Stock | |||||
|---|---|---|---|---|---|
| Number of Shares | Amount | (Accumulated Deficit) Retained Earnings | AOCI* | Total | |
| March 31, 2024 | 5,394,491 | $343,642 | $(183,494) | $(14,755) | $145,393 |
| Exercise of stock options and vesting of restricted stock units | 20,858 | - | - | - | - |
| Tax withholding on vesting of restricted stock units | (6,194) | (571) | - | - | (571) |
| Dividends paid, $0.16 per share | - | - | (863) | - | (863) |
| Stock-based compensation expense | - | 2,928 | - | - | 2,928 |
| Foreign currency translation | - | - | - | 452 | 452 |
| Net income | - | - | 3,388 | - | 3,388 |
| June 30, 2024 | 5,409,155 | $345,999 | $(180,969) | $(14,303) | $150,727 |
| Exercise of stock options and vesting of restricted stock units | 13,006 | - | - | - | - |
| Tax withholding on vesting of restricted stock units | (2,306) | (307) | - | - | (307) |
| Dividends paid, $0.16 per share | - | - | (866) | - | (866) |
| Stock-based compensation expense | - | 3,837 | - | - | 3,837 |
| Foreign currency translation | - | - | - | 4,632 | 4,632 |
| Net income | - | - | 3,428 | - | 3,428 |
| September 30, 2024 | 5,419,855 | $349,529 | $(178,407) | $(9,671) | $161,451 |
| Common Stock | |||||
|---|---|---|---|---|---|
| Number of Shares | Amount | (Accumulated Deficit) Retained Earnings | AOCI* | Total | |
| March 31, 2023 | 5,369,466 | $332,076 | $74,199 | $(12,795) | $393,480 |
| Exercise of stock options and vesting of restricted stock units | 20,074 | 52 | - | - | 52 |
| Tax withholding on vesting of restricted stock units | (5,260) | (712) | - | - | (712) |
| Dividends paid, $0.16 per share | - | - | (859) | - | (859) |
| Stock-based compensation expense | - | 2,968 | - | - | 2,968 |
| Foreign currency translation | - | - | - | (6,661) | (6,661) |
| Net (loss) | - | - | (549) | - | (549) |
| June 30, 2023 | 5,384,280 | $334,384 | $72,791 | $(19,456) | $387,719 |
| Exercise of stock options and vesting of restricted stock units | 7,464 | 304 | - | - | 304 |
| Tax withholding on vesting of restricted stock units | (18) | (2) | - | - | (2) |
| Dividends paid, $0.16 per share | - | - | (862) | - | (862) |
| Stock-based compensation expense | - | 3,183 | - | - | 3,183 |
| Foreign currency translation | - | - | - | (1,353) | (1,353) |
| Net (loss) | - | - | (1,230) | - | (1,230) |
| September 30, 2023 | 5,391,726 | $337,869 | $70,699 | $(20,809) | $387,759 |
*Accumulated Other Comprehensive Income (Loss).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.